Sarasin & Partners LLP Has $518,000 Stake in HCP, Inc. (HCP)

Sarasin & Partners LLP lowered its holdings in shares of HCP, Inc. (NYSE:HCP) by 30.3% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 19,844 shares of the real estate investment trust’s stock after selling 8,633 shares during the period. Sarasin & Partners LLP’s holdings in HCP were worth $518,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Shell Asset Management Co. raised its stake in HCP by 311.9% during the third quarter. Shell Asset Management Co. now owns 121,033 shares of the real estate investment trust’s stock worth $4,806,000 after buying an additional 91,652 shares during the last quarter. Sawyer & Company Inc bought a new position in HCP during the fourth quarter worth $725,000. Beacon Investment Advisory Services Inc. raised its stake in HCP by 109.3% during the third quarter. Beacon Investment Advisory Services Inc. now owns 18,570 shares of the real estate investment trust’s stock worth $517,000 after buying an additional 9,698 shares during the last quarter. California Public Employees Retirement System raised its stake in HCP by 3.9% during the third quarter. California Public Employees Retirement System now owns 1,164,448 shares of the real estate investment trust’s stock worth $32,407,000 after buying an additional 43,888 shares during the last quarter. Finally, Arbor Wealth Management LLC raised its stake in HCP by 10.2% during the third quarter. Arbor Wealth Management LLC now owns 146,389 shares of the real estate investment trust’s stock worth $3,955,000 after buying an additional 13,512 shares during the last quarter. 90.97% of the stock is owned by hedge funds and other institutional investors.

Shares of HCP, Inc. (NYSE HCP) opened at $23.21 on Friday. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 1.17. The company has a market cap of $10,620.61, a price-to-earnings ratio of 20.91, a price-to-earnings-growth ratio of 4.10 and a beta of 0.27. HCP, Inc. has a twelve month low of $22.22 and a twelve month high of $33.67.

The business also recently declared a quarterly dividend, which will be paid on Friday, March 2nd. Shareholders of record on Thursday, February 15th will be issued a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a yield of 6.38%. The ex-dividend date of this dividend is Wednesday, February 14th. HCP’s payout ratio is 133.33%.

A number of equities analysts recently weighed in on HCP shares. Zacks Investment Research downgraded shares of HCP from a “hold” rating to a “sell” rating in a research note on Tuesday, January 2nd. Stifel Nicolaus raised shares of HCP from a “hold” rating to a “buy” rating and set a $29.00 target price for the company in a research note on Tuesday, December 5th. JPMorgan Chase & Co. raised shares of HCP from a “neutral” rating to an “overweight” rating and set a $29.00 target price for the company in a research note on Friday, December 15th. Mizuho raised shares of HCP from a “neutral” rating to a “buy” rating and set a $32.00 target price for the company in a research note on Thursday, November 2nd. Finally, Morgan Stanley reissued an “equal weight” rating and set a $29.00 target price on shares of HCP in a research note on Thursday, December 14th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company’s stock. HCP presently has an average rating of “Hold” and a consensus price target of $30.14.

COPYRIGHT VIOLATION WARNING: “Sarasin & Partners LLP Has $518,000 Stake in HCP, Inc. (HCP)” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://sportsperspectives.com/2018/02/10/sarasin-partners-llp-has-518000-stake-in-hcp-inc-hcp.html.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply